Clinical Trial Update: A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 double-blind trial evaluated BAY1142524 for efficacy, safety and tolerability in patients with type 2 diabetes and diabetic kidney disease; study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• BAY1142524

Snippet

Sponsor: Bayer | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED